| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
K.LTGMAFR.V 2.98 1.19 398.2173 59.75 - 64.56 2 9.1E5 62.00 227 233 N
R.GASQNIIPASTGAAK.A 3.30 2.71 693.3820 49.60 - 55.42 2 6E5 52.70 200 214 N
K.VVPELNGK.L Y 2.20 5.55 428.2562 43.12 - 48.36 2 4.8E5 45.73 219 226 Y
R.VPTPNVSVVDLTVR.L 2.30 1.35 748.4364 102.57 - 105.20 2 3.5E5 104.03 234 247 N
K.LVSWYDNEFGYSHR.V Y 2.17 1.89 591.6131 95.35 - 98.27 3 2.3E5 96.94 309 322 Y
R.VVISAPSADAPMFVMGVNHEK.Y Y 2.34 2.24 733.7112 108.35 - 112.22 3 1.6E5 110.04 118 138 Y
K.AAAEGPMK.G Y 1.02 3.04 387.7021 27.76 - 30.97 2 1.6E5 29.69 263 270 N
K.GILGYTEDQVVSTDFNGDTR.S Y 1.11 1.26 729.6843 103.92 - 110.55 3 9.6E4 107.22 271 290 N
R.VPTPNVSVVDLTVR.L 1.99 0.79 499.2924 102.53 - 105.30 3 7.5E4 104.03 234 247 N
K.LTGMAFR.V 2.10 2.42 795.4279 59.78 - 64.08 1 7.2E4 62.00 227 233 N
R.GASQNIIPASTGAAK.A 2.11 3.28 462.5901 49.53 - 55.29 3 6.5E4 52.69 200 214 N
F.RVPTPNVSVVDLTVR.L 1.66 1.39 551.3285 93.95 - 97.03 3 6.1E4 95.57 233 247 N
R.SSIFDAGAGIALNDHFVK.L 0.58 0.00 621.3255 117.72 - 123.45 3 5.7E4 119.14 291 308 N
K.YDSSMK.V Y 1.56 1.81 365.6618 27.64 - 30.08 2 5.1E4 29.00 139 144 N
R.VCDLVLHMFSK.E Y 1.16 1.22 431.2270 118.50 - 122.12 3 5E4 120.16 323 333 N
K.YDSTHGVWK.L Y 1.28 3.30 546.7680 40.22 - 47.01 2 4.4E4 44.10 47 55 N
Y.DNEFGYSHR.V 1.83 0.51 562.7490 36.35 - 43.69 2 4.4E4 39.36 314 322 N
K.L(+43.01)TGMAFR.V 1.64 2.96 419.7203 102.24 - 105.60 2 3.8E4 104.05 227 233 N Carbamylation
K.RVVISAPSADAPMFVMGVNHEK.Y Y 0.98 0.69 589.5618 100.34 - 103.57 4 3.7E4 101.98 117 138 N
K.LVSWYDNEFGYSHR.V Y 1.64 0.09 886.9134 95.08 - 98.15 2 3.6E4 96.84 309 322 N
R.LEKPAKYDDIKK.V 1.33 4.47 483.2819 31.23 - 35.52 3 3.6E4 33.20 248 259 N
K.VVPELNGK.L Y 1.89 2.11 855.5029 42.00 - 48.40 1 3.5E4 45.44 219 226 N
K.GILGYTEDQVVSTDFNGDTR.S Y 1.55 0.70 1094.0233 105.98 - 109.19 2 3.4E4 107.49 271 290 N
K.YDSTHGVWK.L Y 1.89 5.21 364.8455 40.43 - 47.21 3 3.4E4 44.28 47 55 N
R.VCDLVLHMFSK.E Y 1.25 0.68 646.3394 118.50 - 121.89 2 3.3E4 120.04 323 333 N
K.VVSNASCTTNCLAPVAK.V Y 0.82 1.41 839.4292 65.32 - 70.40 2 3E4 67.62 145 161 N
K.RVVISAPSADAPMFVMGVNHEK.Y Y 1.20 0.53 785.7457 99.64 - 103.90 3 2.9E4 102.03 117 138 N
R.VC(+57.02)DLVLHMFSK.E Y 1.28 1.79 450.2345 108.57 - 112.05 3 2.8E4 110.35 323 333 N Carbamidomethylation
R.LEKPAKYDDIKK.V 0.90 3.08 362.7139 32.81 - 35.55 4 2.7E4 33.94 248 259 N
R.V(+43.01)CDLVLHMFSK.E Y 1.51 0.78 445.5634 111.83 - 115.26 3 2.4E4 113.85 323 333 N Carbamylation
Y.DNEFGYSHR.V 1.59 2.24 375.5012 38.71 - 43.25 3 2.4E4 40.41 314 322 N
R.V(+43.01)CDLVLHMFSK.E Y 0.84 0.56 667.8424 111.67 - 116.27 2 2E4 113.87 323 333 N Carbamylation
R.VVISAPSADAPMFVMGVNHEKYDSSMK.V Y 0.38 0.41 728.3629 107.41 - 109.21 4 1.9E4 108.53 118 144 N
E.YMVYMFK.Y 0.87 0.40 491.2391 95.22 - 97.97 2 1.8E4 97.12 40 46 N
K.YDDIKK.V 0.08 2.68 391.2146 28.80 - 32.49 2 1.6E4 30.33 254 259 N
K.YDDIK.K 0.30 0.33 327.1649 28.73 - 31.98 2 1.6E4 30.51 254 258 N
K.VVSNASCTTNC(+57.02)LAPVAK.V Y 1.46 3.13 867.9367 70.03 - 73.08 2 1.4E4 71.90 145 161 N Carbamidomethylation
R.VC(+57.02)DLVLHMFSK.E Y 0.61 2.74 674.8501 108.61 - 111.42 2 1.3E4 110.20 323 333 N Carbamidomethylation
Y.VVESTGVFTTIEK.A 0.73 1.75 705.3867 82.42 - 84.07 2 1.2E4 83.40 94 106 N
R.L(+43.01)EKPAK.Y 0.18 1.39 364.7140 30.98 - 33.04 2 1.1E4 31.92 248 253 N Carbamylation
R.LEKPAKYDDIKK.V 1.18 2.70 724.4218 31.34 - 35.41 2 1E4 33.35 248 259 N
K.V(+43.01)VSNASCTTNCLAPVAK.V Y 0.42 1.07 860.9329 62.80 - 66.23 2 1E4 64.67 145 161 N Carbamylation
R.VCDLVLHMF.S Y 1.52 2.09 538.7733 131.85 - 132.88 2 9.7E3 132.36 323 331 N
K.L(+43.01)TGMAFR.V 0.41 0.06 838.4307 103.07 - 106.14 1 9.5E3 104.25 227 233 N Carbamylation
K.VVSNASCTTNCLAPVAK(+43.01).V Y 1.04 1.64 860.9343 60.89 - 64.26 2 9.2E3 62.82 145 161 N Carbamylation
K.RVVISAPSADAPMFVMGVNHEKYDSSMK.V Y 0.17 1.44 614.1092 100.33 - 102.18 5 7.8E3 100.98 117 144 N
R.SSIFDAGAGIALNDHFVK.L 0.43 1.83 931.4777 117.95 - 121.45 2 7.7E3 119.11 291 308 N
K.VVNDNFVIVEGLMSTVH.A Y 1.12 1.28 624.9939 131.99 - 133.95 3 7.6E3 133.53 162 178 N
M.VKIGINGFGR.I Y 1.27 10.73 354.2186 71.45 - 74.36 3 7.5E3 73.27 2 11 N
K.VVSNASC(+57.02)TTNCLAPVAK.V Y 0.37 4.21 867.9395 59.32 - 63.55 2 7.3E3 61.61 145 161 N Carbamidomethylation
K.VVNDNFVIVEGLMSTVH.A Y 1.12 0.52 936.9891 133.25 - 134.23 2 6.6E3 133.64 162 178 N
K.VVSNASCTTNC(+57.02)LAPVAK.V Y 0.19 4.31 867.9403 57.71 - 61.07 2 5.8E3 59.54 145 161 N Carbamidomethylation
R.VC(+57.02)DLVLHMF.S Y 0.93 0.65 567.2856 126.66 - 130.26 2 5.7E3 129.34 323 331 N Carbamidomethylation
K.VVSNASC(+57.02)TTNC(+57.02)LAPVAK.V Y 0.34 3.24 896.4573 49.24 - 55.26 2 5.6E3 53.24 145 161 N Carbamidomethylation
K.VVSNASCTTNCLAPVAK.V Y 0.06 5.50 559.9549 67.22 - 68.97 3 5.6E3 67.71 145 161 N
K.I(+43.01)GINGFGR.I Y 0.32 1.58 438.7456 93.04 - 95.72 2 5.2E3 94.47 4 11 N Carbamylation
M.STVHAITATQK.T Y 0.17 0.24 578.8284 32.12 - 34.57 2 5.1E3 33.36 175 185 N
R.VCDLVLHMFSKE Y 1.01 3.41 474.2436 120.60 - 122.90 3 4.6E3 121.95 323 334 N
R.LEKPAKYDDIK.K 0.60 2.20 660.3724 35.74 - 40.13 2 4.6E3 38.29 248 258 N
D.APMFVMGVNHEK.Y 0.41 3.13 453.8957 69.73 - 73.14 3 4.3E3 71.60 127 138 N
R.VC(+57.02)DLVLHMFSKE Y 0.14 1.76 493.2535 111.33 - 113.25 3 3.2E3 112.21 323 334 N Carbamidomethylation
R.V(+43.01)CDLVLHMFSK.E Y 0.05 5.37 667.8422 110.86 - 115.68 2 2.9E3 113.39 323 333 N Carbamylation
R.V(+43.01)C(+45.99)DLVLHMFSK.E Y 0.94 1.46 460.8932 114.56 - 117.02 3 2.9E3 116.17 323 333 N Carbamylation; Beta-methylthiolation
K.L(+43.01)VSWYDNEFGYSHR.V Y 0.32 2.01 908.4271 131.86 - 134.18 2 2.5E3 132.98 309 322 N Carbamylation
R.V(+43.01)PTPNVSVVDLTVR.L 0.57 0.07 769.9405 123.67 - 124.83 2 1.9E3 124.30 234 247 N Carbamylation
R.V(+43.01)CDLVLHMFSKE Y 0.34 0.43 488.5781 114.34 - 116.89 3 1.8E3 115.97 323 334 N Carbamylation
K.L(+43.01)VSWYDNEFGYSHR.V Y 0.20 0.59 605.9525 132.44 - 134.21 3 906.3 133.23 309 322 N Carbamylation
total 67 peptides